Pfizer Ltd. — Regulatory Filings 2019

Nov 27, 2019

Pfizer Limited

The Capital. 1802 I 1 901 . Plot No. C · 70, G Block. Bandra Kurla Complex. Bandra (East). Mumbai 400 051. Tel : +91 22 6693 2000 Fax: +91 22 2654 0274

November 25, 2019

The Corporate Relationship Dept. BSE Limited 1 st Floor, P.J.Towers Dalal Street, Fort Mumbai - 400 001 Scrip Code: 500680

The Manager, Listing Dept. The National Stock Exchange of India Ltd. Exchange Plaza, 5 th Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai - 400 051 Scrip Symbol: PFIZER

Dear Sirs,

Sub: Disclosure under Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

Pursuant to Regulation 23(9) of the Listing Regulations, please find enclosed, disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards for the half year ended September 30, 2019.

The said disclosure is also avai lable on the website of the Company i.e., www.pfizerindia.com.

Please take the above on record .

Thanking you,

Yours truly, For PFIZER LIMITED

Prajeet +~ Nair

Company Secretary

Encl: A/a

CIN : 2t.731 MH1950PLC008311 181 contactus.india@pfizer.com ~ www.pfizerindia.com

PFIZER LIMITED

DISCLOSURE OF RELATED PARTY TRANSACTIONS FOR THE HALF YEAR ENDED SEPTEMBER 30, 2019

Currency: Rs. in Crore

Related party transactions

Transactions during the half year and balances outstanding as at the half year ended September 30, 2019 with the related parties arc as follows:

		Currencv: Rs. in C
	No. Nature of transactions	September 30, 2019
		Ultimate holding company	Companies exercising significant influence	Fellow iaries subsid	Total
I	Service income	-	-	27.41	27.41
	2 Recovery of expenses	-		O.IO	O.IO
	3 Purchase of stock-in-trade	-	-	135.67	135.67
	4 Purchase of raw I bulk materials	-	-	32.04	32.04
	5 lntercompany Liablity written back	-	1.42	8.59	I0.01
	6 Outstanding as at the year end - Due from	-	0.09	21.12	21.21
	7 Outstanding as at the year end - Due to	3.93	2.68	214.80	221.41

Key Managerial Personnel

	Currencv: Rs. in Crore
No. I Nature of transactions	Seotember 30, 2019
I I Remuneration to Kev Managerial Personnel*	3.95

* E"cludes amounts payable to Key Managerial Personnel towards Gratuity and Compensated Absences.

PFIZER LIMITED

DISCLOSURE OF RELAT ED PARTY TRANSACrIONS FOR Tll E llALF YEAR ENDED SEPTEMBER 30, 2019

Related party trans act io ns

Names of related parties and description of relationships

A Parties where control exists:

Ultimate holdi ng company l'lizer Inc. , USA

B Companies collccth•ely exercising sig nificant influence: Plizer East India 13 .V., Netherlands Wyeth LLC. USA Wyeth Holdings Corporartion, USA John Wyeth & Brother Limited, UK Warner Lambert Company, LLC, USA Parke Davis & Company, LLC USA Pharmacia Corporartion, USA [Collectively holding 6 3.92% of the aggregate of equity share capital of the Company]

C Fellow subsidiaries with whom transactions have taken place during the half year

Plizer Products India Private Limited, India Plizer Innovative Supply Point Intl 13VBA, Belgium Pfizer Service Company 13VAA. Belgium Pfizer Worldwide Services, Ireland Pfi zer Overseas LLC - Export Division Plizer Expo rt Cmpany Pfo:e r Enterprises SARL - Sales Division Pfize r Global Trading Pfizer International LLC Pfizer Overseas LLC

D Key Managerial Personnel

Mr. S. Sridhar - Managing Director Mr Mil ind Patil - Whole Time Director Mr. Vivek Dhariwal - Whole Time Director Mr. RA . Shah - Independent Director Mr. l'radip Shah - Independent Director Mr. Uday Khanna - Independent Director Mr. Sunil 1.albhai - Independent Director Ms. Meena Ganesh - Independent Director